Loading clinical trials...

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT03793608

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

The primary objective of the study is to assess the tolerability of peanut protein in pediatric patients (6-17 years old) treated with dupilumab monotherapy, in which tolerability is defined as the pr...

Lead sponsor: Regeneron Pharmaceuticals•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 2

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

NCT03835767 · Milk and/or Peanut Allergy

RECRUITINGPhase 2

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

NCT05695261 · Allergy, Peanut, Peanut Allergy, and more

Enrolling By InvitationPhase 2

Food Oral Immunotherapy for Peanut Allergy

NCT04222491 · Peanut Allergy

Active Not RecruitingNA

Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT

NCT04511494 · Peanut Allergy

AVAILABLE

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

NCT05424731 · Peanut Allergy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 19, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment25

Start dateMar 2019

Last updatedMay 19, 2022

Condition

Peanut Allergy

Locations shown

Regeneron Investigational Site

Mountain View, California

Regeneron Investigational Site

Tampa, Florida

Regeneron Investigational Site

Indianapolis, Indiana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 19, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

Food Oral Immunotherapy for Peanut Allergy

Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Trial snapshot

Condition

Locations shown

For caregivers